Application 761365

Type
BLA
Sponsor
ASTELLAS

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761365Vyloyzolbetuximab-clzb351(a)Rx2026-06-01

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001VYLOYZOLBETUXIMAB-CLZBINJECTABLE;INJECTION100MGNoNo

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 ยท 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
VYLOYZOLBETUXIMABAstellas Pharma US, Inc.e7695a21-abb6-47ac-93f8-0ece5a9c44092025-06-12Warnings, Adverse reactionsExact identifier
application number: BLA761365

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
82509SUPPL 2025-06-09
82492SUPPL 2025-06-09
80234ORIG 2024-11-18
79924ORIG 2024-10-21
79913ORIG 2024-10-18